Understanding Statin Metabolism

Slides:



Advertisements
Similar presentations
© 2006 National Lipid Association Statin Safety: Key Conclusions and Recommendations of the NLA.
Advertisements

Statin Induce Myotoxicity
Muscle pain with taking statin
Statin Myopathy (AHA/ACC/NHLBI)
Perspectives on Managing Polycythemia Vera for the Nurse Practitioner and Physician Assistant.
Statin Selection in the Elderly
Optimizing Statin Therapy
Statin Selection Aimed to Reduce New-Onset DM Risk:
Tailoring Statin Therapy in Women
A multicenter, double-blind, randomized study to establish the clinical benefit and safety of ezetimibe/simvastatin tablet (vytorin) vs simvastatin.
Patient Presentation. Patient Presentation PRIMO Study Incidence of Muscle Adverse Effects.
GAUSS-3 Trial design: Patients with objective evidence of intolerance to statin agents were randomized in a 2:1 fashion to either evolocumab 420 mg subcutaneously.
Challenging Statin Intolerance: Back to Basics
Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?
Metastatic Renal Cell Carcinoma
American Heart Association Scientific Sessions
New Perspectives in AF and PCI: Implications for the Practicing Physician.
Obesity and Dyslipidemia: How Would You Treat?
Statins and the Elderly Patient
Statin Selection in Special Patient Populations: A Case Challenge
Management Considerations in Epilepsy Among Long-Term Care Residents
Oral Anticoagulants in AFa,b A Brief History.
Beyond Statin Therapy.
How to Adjust Anticoagulant Dosing
LDL-C Goals. The Patient With Difficult-to-Treat Hypercholesterolemia: Is Everything Under Control?
Statin Class in Session
Diabetes Increases Risk of CVD
Assessing the State of Statin Therapy
Are We Closer to Personalized Medicine in MS?
Statins, HIV, and CVD.
Evaluating LDL-C Recommendations
What's New in Dyslipidemia?
62-year-old Man With Unstable Angina
Statins and Glucose Metabolism: Are All Agents Alike?
Statin Class in Session
PCP View: ACC/AHA Guidelines: Role of Moderate Intensity Statins
Seizures in the Elderly: Treatment and Special Considerations
Personalizing Statin Therapy in Patients With HIV
A Journal Club on Lipid Management:
Overview. 5 Things You Need to Know About Statin Selection in Patients With HIV Infection.
Learning Objectives Classification of VTE Goals of VTE Treatment.
A Patient Journey Through Statin Intolerance
Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors
Statins and HIV:.
Exploring Statin Intolerance
New Horizons in Adjunctive Type 1 Diabetes Management With SGLT Inhibitors.
Lipid Clinic Challenge
Statins, HIV, and CVD.
Clinicians' Corner in Dyslipidemia
Residual CV Risk in Patients With Dyslipidemia and Stable CAD
Definition of Elderly. Advanced Age and CV Risk: To Start or Not to Start a Statin in Older Patients?
What You Didn't Know About AF and Renal Dysfunction
Statins, Obesity, and Hyperlipidemia
VOD/SOS: Aligned Education for Patients and the Interprofessional Team
Glucose Management and Statin Therapy
Add-On Therapy to Insulin in T1DM Management
Approximate Dose Equivalency of Statin LDL-C Efficacy.
New Lipid-Lowering Guidelines
Statins and Glucose Metabolism: An Endocrinology Perspective
Glucose Management and Statin Therapy
The Nurse View: Spotlight on EGFR-Mutated NSCLC
PCSK9 Inhibitors and Statin Intolerance
Updates on Dyslipidemia
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
How to Adjust Anticoagulant Dosing
Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.
Statin Selection in Patients With Pre-Diabetes: Case Considerations
Statin Therapy in Patients With Insulin Resistance
Lipids, the Heart, and the Kidney
PCSK9 Inhibitors and Real-World Evidence
Presentation transcript:

Understanding Statin Metabolism

Patients Most at Risk For Statin-Drug Interactions

Common Drug Classes That May Interact With Statins

Basics of Statin Metabolism

What Happens to Statins in the Body?*

Hydrophilic vs Lipophilic Statins

"First Pass" Metabolism

"First Pass" Metabolism (cont)

"First Pass" Metabolism (cont)

Molecular Structure of Statins

Statin Drug Properties Overview

Selected Drug Interactions That Increase Statin Levels

Statin-Associated Myopathy Risk Factors

Statin Dosing Considerations

Simvastatin Label Change Due to Drug Interactions

Gender Differences in Response to Statins

Racial Differences in Response to Statins

INTREPID Trial Statin Therapy in HIV Patients

INTREPID Trial Results

REPRIEVE Trial

REPRIEVE Trial Hypotheses

Why Pitavastatin?

Statin Dose Adjustment Based on Renal Function

Intensity of Statin Therapy

Statin-Associated Muscle Symptoms vs Statin Intolerance

Management of Statin-Related AEs

Clinical Management of the Patient

Conclusion

Abbreviations

Abbreviations (cont)

Abbreviations (cont)